Wis. Admin. Code Controlled Substances Board CSB 2.75

Current through December 30, 2024

Section CSB 2.75 - Exclusion of approved cannabidiol drugs from schedule I

(1) Section 961.14(4) (t)4, Stats., is created to read:

961.14 (4) (t) 4. A drug product in finished dosage formulation that has been approved by the United States food and drug administration that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) derived from cannabis and no more than 0.1 percent (w/w) residual tetrahydrocannabinols.

(2) Section 961.22(7) is repealed.

Wis. Admin. Code Controlled Substances Board CSB 2.75

Adopted by, cr. Affirmative action order under s. 961.11(4g), Stats., Register June 2020 No. 774, eff. 6/29/2020

Amended by, CR 20-077: cr. Register July 2021 No. 787, eff. 8/1/2021